Media Database
>
Jayson Maclean

Jayson Maclean

Author at cantechletter.com at Cantech Letter

Contact this person
Email address
j*****@*******.comGet email address
Influence score
29
Location
Canada
Languages
  • English
Covering topics

    View more media outlets and journalists by signing up to Prowly

    View latest data and reach out all from one place
    Sign up for free

    Recent Articles

    cantechletter.com

    Spectral Medical is undervalued, says Paradigm

    Paradigm Capital analyst Scott McAuley likes what he sees in clinical stage medical device company Spectral Medical, saying in a Wednesday update that the stock is clearly undervalued at current levels.
    cantechletter.com

    Cresco Labs is a pass, says Echelon

    It’s still a “Hold” on US cannabis name Cresco Labs, according to Echelon Capital Markets analyst Andrew Semple, who reviewed Cresco’s latest quarterly results in a Wednesday report.
    cantechletter.com

    Village Farms is tops in cannabis, says Beacon

    Beacon Securities analyst Doug Cooper provided an update to clients on Tuesday where he reiterated a “Buy” rating on cannabis stock Village Farms.
    cantechletter.com

    13 AI stocks for your portfolio

    EIght Capital published a report on Tuesday outlining ways in which 13 companies in their coverage universe will benefit from generative AI.
    cantechletter.com

    Arch Biopartners is a pass, says Raymond James

    Raymond James analyst Rahul Sarugaser is sticking with a Market Perform rating on Arch Biopartners, saying in a Tuesday update that caution is the wise approach.
    cantechletter.com

    Haivision Systems is a Buy, says Paradigm

    Streaming video tech company Haivision Systems received a “Buy” rating from Paradigm Capital in a coverage initiation on Tuesday.
    cantechletter.com

    Here’s why H2O Innovation stock is still a Buy

    iA Capital Markets analyst Naji Baydoun argues in a Thursday report that there are plenty of reasons to still be liking H2O Innovation.
    cantechletter.com

    Three cinema stocks reviewed by Roth

    Roth Capital Partners analyst Eric Handler reviewed the latest results and coming attractions from the cinema market on Monday and reiterated a “Buy” rating on IMAX.
    cantechletter.com

    Innergex is a “Strong Buy,” says iA Capital

    iA Capital Markets analyst Naji Baydoun provided an update on Innergex Renewable Energy on Tuesday where he reiterated a Strong Buy on the stock.
    cantechletter.com

    Loop Industries is practically a double, says Roth

    Roth Capital Partners analyst Gerry Sweeney is keeping a bullish stance on Canadian cleantech company Loop Industries in a Friday report.
    cantechletter.com

    Kits Eyecare is heading even higher, says Beacon

    The stock has already had a tremendous 2023, but investors can expect even more upside from Kits Eyecare, according to Beacon Securities analyst Doug Cooper, who provided an update to clients on Monday.